Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation

Bone Marrow Transplantation

Volumn 25, Issue 12, 2000, Pages 1223-1228

  Vij, R ^a   Brown, R ^a   Shenoy, S ^a   Haug, J S ^a   Kaesberg, D ^a   Adkins, D ^a   Goodnough, L T ^a   Khoury, H ^a   DiPersio, J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic transplantation; CD34 selection; Cytokines; Dendritic cells; GVHD

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; CYTOKINE; ETOPOSIDE; GAMMA INTERFERON; GANCICLOVIR; HLA ANTIGEN; INTERLEUKIN 8; ISOTONIC SOLUTION; METHYLPREDNISOLONE; PREDNISONE; SILICON DIOXIDE; THYMOCYTE ANTIBODY;

ALLOTRANSPLANTATION; ARTICLE; CELL SELECTION; CLINICAL ARTICLE; CLINICAL TRIAL; COLLOID; DENSITY GRADIENT CENTRIFUGATION; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MORBIDITY; MORTALITY; MYELODYSPLASIA; MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033948934     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702427     Document Type: Article

References (29)

1. Brown R, Adkins D, Khoury H et al. Long term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality. J Clin Oncol 1999; 17: 806-812.
2. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with high risk of chronic graft-versus-host disease. Blood 1997; 12: 4705-4709.
3. Verdonck L, Dekker A, de Gast GC et al. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood 1994; 83: 3090-3096.
4. Przepiorka D, Van Vlasselaer P, Huynh L et al. Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semi automated density gradient centrifugation in a closed system. J Hematother 1996; 5: 497-502.
5. Laport GF, Zimmerman TM, Grinblatt DL et al. Final update: a phase I/II trial of the ACT CD 34+ enrichment kit to enrich mobilized peripheral blood progenitor cells for breast cancer patients receiving high dose chemotherapy. Blood 1998; 92 (Suppl. 1): 312b (Abstr. 4344).
6. Brown R, Adkins D, Goodnough L et al. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies. J Clin Oncol 1997; 15: 3067-3074.
7. Roscoe RA, Rybka WB, Winkelstein A et al. Enumeration of CD34+ hematopoietic stem cells for reconstitution following myeloablative therapy. Cytometry 1994; 16: 74-79.
8. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
9. Shulman H, Sullivan K, Weiden P et al. Chronic graft-versus-host syndrome in man. Am J Med 1980; 69: 204-217.
10. Hale G, Waldmann H. Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection. Bone Marrow Transplant 1996; 17: 305-308.
11. Fischer A, Durandy A, de Villartay J et al. HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine. Blood 1986; 67: 444-449.
12. Wagner J, Donnenberg A, Noga S et al. Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial. Blood 1988; 72: 1168-1176.
13. Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatibility parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983; 61: 341-348.
14. O'Reilly R, Collins N, Brochstein J et al. Soyabean lectin agglutination and E rosette depletion for removal of T cells from HLA identical marrow grafts: results in 60 consecutive patients transplanted for hematopoietic malignancy. In: Hagenbeck A, Lowenberg B (eds). Minimal Residual Disease in Acute Leukemia. Martins Nijhoff: Zoetermeer, The Netherlands, 1986; pp. 337-433.
15. + cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Bone Marrow Transplant 1998; 22: 519-525.
16. + progenitor cells from matched related donors. Bone Marrow Transplant 1996; 18: 1081-1086.
17. Garcia-Conde J, Martin-Gaitero M, Arbona C et al. High frequency of chronic graft versus host disease (GVHD) associated with unmodified allogeneic peripheral blood progenitor cell transplantation (Allo-PBPCT). Preliminary results of allogeneic CD34+ selected cell PBPCT. Blood 1996; 88 (Suppl. 1): 261a (Abstr. 1031).
18. Bensinger W, Buckner C, Shannon-Dorcy K et al. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996; 88: 4132-4138.
19. Link H, Arseniev L, Bahre O et al. Transplantation of allogeneic CD34+ blood cells. Blood 1996; 87: 4903-4909.
20. Bensinger W, Rowley S, Appelbaum F et al. CD34 selected allogeneic peripheral blood stem cell transplantation in older patients with advanced hematologic malignancies. Blood 1995; 86 (Suppl. 1): 97a (Abstr. 376).
21. Bertolini F, Thomas T, Battaglia M et al. A new 'two step' procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation. Bone Marrow Transplant 1997; 19: 615-619.
22. + cells and progenitor cell recoveries. Bone Marrow Transplant 1998; 22: 117-124.
23. Read EJ, Vigue FE, Carter CS et al. Clinical trial of automated 2-step T-cell depletion of peripheral blood progenitor cells for matched related allogeneic transplant. Blood 1998; 92 (Suppl. 1): 446a (Abstr. 1846).
24. Hertenstein B, Arseniev L, Novotny J et al. Transplantation of CD34+ selected blood cells for HLA-identical sibling donors - Impact on CMV-infection and relapse. Blood 1997; 90 (Suppl. 1): 103a (Abstr. 453).
25. Troutt A, Kelso A. Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR. Proc Natl Acad Sci USA 1992; 89: 5276-5280.
26. Kelso A. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction. J Immunol 1990; 145: 2167-2176.
27. Smith S, Terminelli C, Kenworthy-Bott L et al. A study of cytokine production in acute graft-vs-host disease. Cell Immunol 1991; 134: 336-348.
28. Velardi A, Varese P, Terenzi A et al. Lymphokine production by T-cell clones after human bone marrow transplantation. Blood 1989; 74: 1665-1672.
29. Uguccioni M, Meliconi R, Nesci S et al. Elevated interleukin-8 serum concentrations in beta-thalassemia and graft-versus-host disease. Blood 1993; 81: 2252-2256.